Mitochondrial involvement in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurochemistry International

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0197-0186(01)00124-3PMID 11850110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal

  2004cited by this paper
• Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

  2000cited by this paper
• Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.

  2000cited by this paper
• Oxidants, oxidative stress and the biology of ageing

  2000cited by this paper
• Protective Effect of Harmalol and Harmaline on MPTP Neurotoxicity in the Mouse and Dopamine‐Induced Damage of Brain Mitochondria and PC12 Cells

  2000cited by this paper
• Interaction Among Mitochondria, Mitogen‐Activated Protein Kinases, and Nuclear Factor‐κB in Cellular Models of Parkinson's Disease

  2000cited by this paper
• Mice Lacking a-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine

  2000cited by this paper
• Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons

  2000cited by this paper
• Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.

  2000cited by this paper
• Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants

  2000cited by this paper
• A Drosophila model of Parkinson's disease

  2000cited by this paper
• Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein.

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity

  2000cited by this paper
• Variability and validity of polymorphism association studies in Parkinson’s disease

  2000cited by this paper
• alpha-synuclein promotes mitochondrial deficit and oxidative stress.

  2000cited by this paper
• Dopamine‐Induced Apoptosis Is Mediated by Oxidative Stress and Is Enhanced by Cyanide in Differentiated PC12 Cells

  2000cited by this paper
• Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease

  2000cited by this paper
• Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts.

  2000cited by this paper
• Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Modulation of brain mitochondrial membrane permeability and synaptosomal Ca2+ transport by dopamine oxidation

  1999cited by this paper
• The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

  1999cited by this paper
• Prostate Apoptosis Response‐4 Production in Synaptic Compartments Following Apoptotic and Excitotoxic Insults

  1999cited by this paper
• Parkinson disease in twins: an etiologic study.

  1999cited by this paper
• The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins

  1999cited by this paper
• Increased 8‐oxo‐dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease

  1999cited by this paper
• Participation of prostate apoptosis response‐4 in degeneration of dopaminergic neurons in models of Parkinson's disease

  1999cited by this paper
• Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria

  1999cited by this paper
• Pramipexole Reduces Reactive Oxygen Species Production In Vivo and In Vitro and Inhibits the Mitochondrial Permeability Transition Produced by the Parkinsonian Neurotoxin Methylpyridinium Ion

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

  1998cited by this paper
• Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• Injected cytochrome c induces apoptosis

  1998cited by this paper
• Toxicity of Dopamine to Striatal Neurons In Vitro and Potentiation of Cell Death by a Mitochondrial Inhibitor

  1998cited by this paper
• Genetics of Parkinson's disease

  1998cited by this paper
• Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*

  1998cited by this paper
• Protein Nitration in Parkinson's Disease

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species.

  1997cited by this paper
• In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

  1997cited by this paper
• Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Activation of NF‐κB protects hippocampal neurons against oxidative stress‐induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration

  1997cited by this paper
• Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.

  1997cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997cited by this paper
• Cytochrome c: can't live with it--can't live without it.

  1997cited by this paper
• The ‘common deletion’ is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction

  1997cited by this paper
• Mitochondrial respiratory chain function in multiple system atrophy

  1997cited by this paper
• Oxidation of dopamine in the presence of cysteine: characterization of new toxic products.

  1997cited by this paper
• Mitochondrial control of apoptosis.

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

  1997cited by this paper
• Origin and functional consequences of the complex I defect in Parkinson's disease

  1996cited by this paper
• Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons

  1996cited by this paper
• Histochemical detection of apoptosis in Parkinson's disease.

  1996cited by this paper
• Respiratory‐chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients

  1996cited by this paper
• Effect of Dopamine, Dimethoxyphenylethylamine, Papaverine, and Related Compounds on Mitochondrial Respiration and Complex I Activity

  1996cited by this paper
• Mitochondrial permeability transition is a central coordinating event of apoptosis

  1996cited by this paper
• The mutation rate of the human mtDNA deletion mtDNA4977.

  1996cited by this paper
• Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

  1996cited by this paper
• Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

  1996cited by this paper
• Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity

  1996cited by this paper
• L‐Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain

  1995cited by this paper
• Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo

  1995cited by this paper
• Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

  1995cited by this paper
• Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease

  1994cited by this paper
• Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.

  1994cited by this paper
• Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy.

  1994cited by this paper
• Complex I, Iron, and ferritin in Parkinson's disease substantia nigra

  1994cited by this paper
• A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia.

  1994cited by this paper
• Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.

  1994cited by this paper
• An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease

  1994cited by this paper
• Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

  1994cited by this paper
• Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide

  1994cited by this paper
• Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease.

  1993cited by this paper
• Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients

  1993cited by this paper
• No evidence for altered muscle mitochondrial function in Parkinson's disease.

  1993cited by this paper
• Pathological implications of nitric oxide, superoxide and peroxynitrite formation.

  1993cited by this paper
• Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease.

  1993cited by this paper
• Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain

  1993cited by this paper
• Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease

  1993cited by this paper
• Progression after chronic manganese exposure

  1993cited by this paper
• Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

  1993cited by this paper
• Is Parkinson's disease a mitochondrial disorder?

  1992cited by this paper
• Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.

  1992cited by this paper
• Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease.

  1992cited by this paper
• Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.

  1992cited by this paper
• Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

  1992cited by this paper
• Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts.

  1992cited by this paper
• Mitochondrial function in Parkinson's disease

  1992cited by this paper

• Parkinson's disease‐linked Kir4.2 mutation R28C leads to loss of ion channel function

  2025cites this paper
• Neuroprotection of Truncated Peptide IIAVE from Isochrysis zhanjiangensis: Quantum Chemical, Molecular Docking, and Bioactivity Studies

  2024cites this paper
• PINK1-G411S mutant increases kinase stability and enhances mitochondrial-linked functions

  2024cites this paper
• Role of mitochondria DNA A10398G polymorphism on development of Parkinson's disease: A PRISMA‐compliant meta‐analysis

  2022cites this paper
• The Positive Role and Mechanism of Herbal Medicine in Parkinson's Disease

  2021cites this paper
• Linking aging and animal models to neurodegeneration

  2021cites this paper
• Regulation

  2020cites this paper
• Irradiation effects on chemical and functional qualities of ready-to-eat Saengshik, a cereal health food

  2020cites this paper
• Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K/Akt/mTOR signaling pathway.

  2020cites this paper
• Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response

  2020cites this paper
• A systems toxicology approach to compare the heavy metal mixtures (Pb, As, MeHg) impact in neurodegenerative diseases.

  2020cites this paper
• The relevance of the supramolecular arrangements of the respiratory chain complexes in human diseases and aging.

  2019cites this paper
• Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

  2019cites this paper
• Ammonia inhibits energy metabolism in astrocytes in a rapid and GDH2-dependent manner

  2019cites this paper
• PET Imaging of Mitochondrial Function in the Living Brain

  2019cites this paper
• Auraptene Mitigates Parkinson’s Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species

  2019cites this paper
• Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

  2018cites this paper
• Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular mechanism of neurodegenerative diseases.

  2018cites this paper
• Bioenergetic regulation of microglia

  2018cites this paper
• Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug‐Induced Liver Injury

  2018cites this paper
• Opicapone, a Novel Catechol‐O‐Methyltranferase Inhibitor (COMT) to Manage the Symptoms of Parkinson's Disease

  2018cites this paper
• Expanding Insights of mitophagy and mitochondrial morphology in a Parkinson's Disease Genetic Model

  2017cites this paper
• The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2

  2017cites this paper
• Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway

  2017cites this paper
• Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

  2017cites this paper
• Relationship between mitochondrial DNA A10398G polymorphism and Parkinson's disease: a meta-analysis

  2017cites this paper
• Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys

  2017cites this paper
• DJ‐1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7

  2017cites this paper
• Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond.

  2017cites this paper
• Neural-specific deletion of mitochondrial p32/C1qbp leads to leukoencephalopathy due to undifferentiated oligodendrocyte and axon degeneration

  2017cites this paper
• Natural Products Combating Neurodegeneration: Parkinson's Disease.

  2017cites this paper
• A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein

  2016cites this paper
• SYNTHESIS AND CHARACTERIZATION OF BRAIN PENETRANT PRODRUG OF NEUROPROTECTIVE D 264 : POTENTIAL DISEASE MODIFYING TREATMENT AGENT FOR PARKINSON ’ S DISEASE By

  2016cites this paper
• Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function

  2016cites this paper
• Polygonum multiflorum extracts protect the SH-SY5Y cells against the oxidative stress injury induced by MPP+

  2016cites this paper
• Mitochondrial NADH Dehydrogenase Subunit 3 Polymorphism Associated with an Earlier Age at Onset in Male Machado–Joseph disease Patients

  2016cites this paper
• The role of sirtuin 2 in oligodendroglia on dopaminergic neuron differentiation and regeneration

  2016cites this paper
• Evaluation of Antiparkinson’s activity of Uncaria rhynchophylla, Mentha aquatica and Banisteriopsis caapi-plants with Monoamine Oxidase-B (MAO-B) inhibition potential.

  2015cites this paper
• Catalpol: a potential therapeutic for neurodegenerative diseases.

  2015cites this paper
• The molecular mechanism of Chinese medicine Uncaria Rhynchophylla (gouteng) for inducing autophagy and protecting neurons in Parkinson's disease

  2015cites this paper
• Metabolic implications and characterization of hepatic extracellular vesicles in drug-induced liver injury

  2015cites this paper
• New insights on Parkinson’s disease genes: the link between mitochondria impairment and neuroinflammation

  2015cites this paper
• Opposing effects of ketamine and acetyl L-carnitine on the serotonergic system of zebrafish.

  2015cites this paper
• Biochemical protective effect of 1,25-dihydroxyvitamin D3 through autophagy induction in the MPTP mouse model of Parkinson’s disease

  2015cites this paper
• Inhibit Dopamine Release Axons: One Source of a Retrograde Signal That Can Striatal Medium Spiny Neurons But Not Dopamine Generation in

  2015cites this paper
• Tetranectin gene deletion induces Parkinson's disease by enhancing neuronal apoptosis.

  2015cites this paper
• Parkinson's disease as a result of aging

  2015cites this paper
• TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells.

  2015cites this paper
• Skeletal muscle mitochondria of NDUFS4-/- mice display normal maximal pyruvate oxidation and ATP production.

  2015cites this paper
• Regulation of DJ-1 Expression by Neuron-Astrocyte Interaction

  2014cites this paper
• Genetic variability of respiratory complex abundance, organization and activity in mouse brain

  2014cites this paper
• Synthesis And Characterization Of Brain Penetrant Prodrug Of Neuroprotective D264: Potential Disease Modifying Treatment Agent For Parkinson's Disease

  2014cites this paper
• Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.

  2014cites this paper
• Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease

  2014cites this paper
• Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity

  2013cites this paper
• Monomer DJ-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of DJ-1 Mutants

  2013cites this paper
• Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.

  2013cites this paper
• Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds

  2013cites this paper
• Neuroprotective Function of DJ-1 in Parkinson's Disease

  2013cites this paper
• Acetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos.

  2013cites this paper
• The Iron-Binding Protein Lactoferrin Protects Vulnerable Dopamine Neurons from Degeneration by Preserving Mitochondrial Calcium Homeostasis

  2013cites this paper
• Research article STUDIES ON BEHAVIORAL, BIOCHEMICAL, IMMUNOHISTOCHEMICAL AND QUANTIFICATION OF DOPAMINE AND ITS METABOLITES IN THE STRIATUM OF 6- HYDROXY DOPAMINE INDUCED PARKINSONISM IN RATS - ATTENUATION BY BACOSIDE- A, A MAJOR PHYTOCONSTITUENT OF BACOPA MONNIERA.

  2013cites this paper
• Estudo dos efeitos neuroprotetor e antioxidante do óleo de peixe em modelo animal de doença de Parkinson

  2013cites this paper
• Funktionelle Charakterisierung eines neuen Proteins mit einer Superoxiddismutase- Domäne

  2013cites this paper
• The Role of Oxidative Stress in Parkinson's Disease

  2013cites this paper
• Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment.

  2012cites this paper
• Brain Ascorbate: Protective, Yet Permissive for Redox Signaling

  2012cites this paper
• Molecular insights into Parkinson's disease.

  2012cites this paper
• Mitochondrial dynamics and neuronal fate in Parkinson's disease.

  2012cites this paper
• Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

  2012cites this paper
• O efeito da acupuntura, eletroacumpuntura e estimulação nervosa elétrica transcutânea no tratamento dos sintomas de Bradicinesia e hipocinesia na Doença de Parkinson : uma nova perspectiva

  2011cites this paper
• Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity

  2011influential citation
• To live or to die: a matter of processing damaged DNA termini in neurons

  2011cites this paper
• Protective Effects of Decursin and Decursinol Angelate against Amyloid β-Protein-Induced Oxidative Stress in the PC12 Cell Line: The Role of Nrf2 and Antioxidant Enzymes

  2011cites this paper
• Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells.

  2011cites this paper
• Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

  2011cites this paper
• Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies.

  2011cites this paper
• Mitochondrial fusion and fission regulation in Parkinson’s Disease

  2011cites this paper
• Mortalin inhibition in experimental Parkinson's disease

  2011cites this paper
• Systemic administration of catalpol prevents D-galactose induced mitochondrial dysfunction in mice.

  2010cites this paper
• The Effects of Oxidative Stress on Calcineurin Activity and DJ-1 Subcellular Localization

  2010cites this paper
• Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production.

  2010cites this paper
• Targeting Glial Cells to Elucidate the Pathogenesis of Huntington’s Disease

  2010cites this paper
• Parkinson’s disease: oxidative stress and therapeutic approaches

  2010cites this paper
• The transition metals copper and iron in neurodegenerative diseases.

  2010cites this paper
• Generation and analysis of a Pink1 deficient mouse model for Parkinson's disease

  2010cites this paper
• Protein Redox-Regulation Mechanisms in Aging

  2010cites this paper
• Toxicology and safety of COMT inhibitors.

  2010cites this paper
• Neuroprotective Effect of Rosmarinus officinalis Extract on Human Dopaminergic Cell line, SH-SY5Y

  2010cites this paper
• Mitochondrial proteomics as a selective tool for unraveling Parkinson’s disease pathogenesis

  2010cites this paper
• Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence

  2010cites this paper
• Toxicity in Amyloid Diseases

  2010cites this paper
• Effects of MPP+ on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells.

  2010cites this paper
• Approaches and Models for Evaluating the Toxic Effects of Anesthetics in the Developing Nervous System

  2010cites this paper
• Author ' s personal copy Mitochondrial ABC proteins in health and disease

  2009cites this paper
• Effects of catalpol on mitochondrial function and working memory in mice after lipopolysaccharide-induced acute systemic inflammation.

  2009cites this paper
• DJ-1 binds to mitochondrial complex I and maintains its activity.

  2009cites this paper
• Emerging roles of mitochondrial membrane dynamics in health and disease

  2009cites this paper
• Mitochondrial ABC proteins in health and disease.

  2009cites this paper
• Mitochondrial dynamics in Parkinson's disease.

  2009cites this paper